Ignite Creation Date:
2025-12-25 @ 2:40 AM
Ignite Modification Date:
2026-03-01 @ 12:17 AM
Study NCT ID:
NCT04659434
Status:
UNKNOWN
Last Update Posted:
2020-12-09
First Post:
2020-11-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Sintilimab Plus R-GemOx as Second-line Salvage Therapy in Patients With R/R DLBCL
Sponsor:
Qian Wenbin
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
IR2020001398
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None